However, it is reasonable to assume that the beneficial effects of liraglutide and other GLP-1 RAs on the individual histologic scores of NASH are multifactorial and a consequence of their combined effects on hyperglycemia/insulin resistance, weight loss and a direct beneficial effect on the liver (beyond the reduction in body weight and hyperglycemia). This evidence concerns the gene GLP1R and Hyperglycemia.